Kyle Breidenstine

Kyle serves as Vice President, Finance & Controller at PepGen. Kyle played a key role in PepGen’s initial public offering, and he has led the finance team’s transition to a public company, including the build-out of the accounting, public company reporting, and FP&A functions. Prior to PepGen, Kyle held roles of increasing responsibility with the finance group at Orchard Therapeutics, where he was a key partner in the Company’s IPO and multiple successful equity offerings. Kyle became a CPA in 2012 and worked in the PwC assurance practice, supporting public and private clients in the biotech and healthcare industries. He began his career in finance working as a budget analyst for the Commonwealth of Massachusetts.

Kyle holds his MBA from the D’Amore-McKim School of Business at Northeastern University and his B.A. from Clark University.